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Artificial Intelligence (AI) arguably represents a 
key technology for the digitalization of health care. 
Specifically, health insurers can benefit from AI as they 
typically have access to vast amounts of data. However, 
practitioners struggle to adopt AI in productive use, and 
extant research lacks an overview of use cases for AI in 
health insurance as well as prioritization criteria that 
can guide their implementation. To address this gap, we 
conduct explorative interviews in the context of the 
German statutory health insurance system. We identify 
AI use cases in the areas of predictive health, 
individualized service, anomaly detection, and 
operations enhancement. We find that health insurers 
are likely to prioritize these use cases according to 
implementation complexity and business orientation, 
whereas focusing on simple use cases that target cost 
savings is recommended by experts. Our study advances 
the understanding of AI adoption in health insurance 
and supports practitioners in guiding future AI 
initiatives. 
1. Introduction  
Artificial Intelligence (AI) is widely viewed as a 
key technology for the digitalization of health care [1]. 
AI compromises a broad suite of different technologies, 
including machine learning, computer vision, natural 
language processing, and robotics [2]. It can be applied 
in health care to augment diagnosis generation and 
therapy selection, predict risks and diseases, reduce 
medical error, or enhance productivity [1, 3]. For 
example, computer vision can be leveraged to augment 
doctors' capabilities in cancer detection [4], or 
augmented reality can support wound management for 
hands-free service innovation [5]. By improving quality 
and efficiency in health care, AI is expected to lower 
health expenditures by billions within the next 10 years, 
even when only considering Europe [6]. 
While all stakeholders are expected to benefit from 
AI, health insurers, especially, are in a promising 
position as they represent the central interface among 
service providers, producers, and insured persons. For 
them, new opportunities come through using the vast 
amounts of data they possess, especially health-related 
data [7]. These data enable the broad use of AI across 
all business areas in health insurance. Furthermore, 
regulatory adjustments allow the data to be further used 
effectively in a way that was not possible before. By 
using these data to implement AI systems, health 
insurers are expected to achieve internal improvements 
through cost savings and process optimization, 
including increased customer satisfaction through 
improved quality of care and individualized 
communication with insured persons. 
Nevertheless, AI adoption proves to be a 
challenging endeavor in practice [8, 9]. Healthcare 
organizations, especially, are facing multiple challenges 
for AI adoption, including strong regulations, the 
sensitivity of health data, the integration of AI systems 
into existing workflows, patient safety and acceptance, 
and the need for ethical considerations [3, 10]. Given 
these challenges and the high failure rate of AI projects 
in practice [8], organizations need to carefully prioritize 
and select use cases for AI adoption [11]. 
Against this background, current research on AI 
adoption faces two limitations. First, despite health 
insurers' promising position, current research still lacks 
an in-depth investigation of AI adoption for health 
insurance. Findings from other domains might not 
transfer seamlessly [e.g., 12, 13, 14], as they do not 
account for context-specific aspects. Second, extant 
research on AI adoption predominately views AI as a 
monolithic concept, meaning that AI is viewed as a 
homogeneous set of use cases and technologies. 
However, AI can be applied in a plethora of use cases 
while using different technologies [2]. Hence, a more 
nuanced perspective on different use cases should be 
applied in researching AI adoption to develop a better 
understanding of how AI use cases are prioritized in 
practice. More research is needed in these areas to 
provide guidance for AI adoption in health insurance. 





To address this, we ask the following research 
questions: 
 
1) What are use cases for AI in health insurance? 
 
2) How do health insurers prioritize AI use cases? 
 
To answer these research questions, we conducted 
explorative interviews with experts from industry and 
consulting in the German statutory health insurance 
system. This approach allowed us to explore AI use 
cases in health insurance and derive criteria that are 
applied for use case prioritization. We identified a 
plethora of AI use cases in the areas of predictive health, 
individualized service, anomaly detection, and 
operations enhancement. Furthermore, we discovered 
that health insurers are likely to prioritize AI use cases 
according to implementation complexity and business 
orientation. Experts recommend health insurers with 
little experience in AI and digital technologies to start 
with simple use cases that primarily target cost savings 
and efficiency gains. More complex use cases typically 
require more investment and, in some instances, change 
current service portfolios. This observation also 
highlights the importance of strategic considerations for 
AI use case prioritization. 
This study contributes to the discourse on AI 
adoption within and outside health care. We enhance our 
understanding of AI adoption in health insurance with 
its unique regulatory context and the sensitivity of the 
data. We provide a novel perspective on AI adoption by 
differentiating between use cases (with distinct 
characteristics), instead of viewing AI as monolithic 
concept; research and practice should consider AI 
adoption in a more nuanced way. Health insurance 
practitioners might use our findings as a starting point 
for their AI adoption decision making. We provide a 
structured list of AI use cases and criteria for use case 
prioritization. 
2. Background 
For the background of this study, we briefly 
describe the context of the German statutory health 
insurance system. Thereafter, we present related work 
on AI adoption within and outside health care. 
2.1 German Statutory Health Insurance 
Statutory health insurance is part of the German 
social system and central to their healthcare system. It is 
meant to “maintain, restore, or improve the health of the 
insured” (§ 1 German Social Code V). Alongside private 
health insurers, they are the main funding bodies for the 
services provided in the German healthcare system. The 
future viability of the healthcare system has increasingly 
become the focus of political and public attention in 
recent years. Statutory health insurers are caught 
between a shortage of skilled workers, funding gaps, 
and a nursing shortage against digitization, innovation, 
and new technologies [15]. On the one hand, statutory 
health insurers are required to reduce expenses for 
service and administrative tasks; on the other hand, they 
inevitably need to undergo costly digital transformation 
to remain competitive [16]. The effective use of the data 
that health insurers have at their disposal is expected to 
play a central role in this scenario [7]. Making use of 
their data can be achieved with the help of AI, but health 
insurers need to adequately prepare for this strategically. 
2.2 Related Work on AI Adoption 
Extant research has identified a plethora of factors 
that influence the AI adoption decision-making process. 
Various contexts have been studied, including public 
health care, car manufacturing, tourism, and financial 
industries [10, 12-14, 17]. Following the works of 
Depietro, et al. [18] and Rogers [19], these influencing 
factors can be organized using the technology, 
organization, and environment framework (Figure 1). 
 
Figure 1. Technology, organization, and 
environment framework [18, 19] 
From a technological perspective, several factors 
influence AI adoption. First, organizations need to 
assess whether AI technology provides a relative 
advantage as compared with traditional IT [13]. AI 
implementation typically is more complicated, which 
might raise concerns about its benefits. Second, 
organizations require the presence of adequate IT 
infrastructure for AI, which compromises AI-specific 
tools (e.g., AI engines and analytical sandboxes) as well 
as the compatibility of existing IT systems with AI 
systems [9, 17, 20]. Third, organizations require training 
data in sufficient quality and quantity for AI 















relevant because today's AI systems are mostly based on 
machine learning from data. 
 From an organizational perspective, AI adoption is 
facilitated by the presence of several factors. First, 
organizations need access to specific human resources 
and expertise to implement AI [9, 22]. Beyond technical 
know-how, this access to human resources and expertise 
also includes AI awareness in management and “AI 
translators” [22]. Second, research has highlighted the 
need for top management commitment as AI adoption 
typically requires larger investments [12, 14, 22] where 
a dedicated AI budget is expected to drive AI adoption 
in organizations [12]. Third, employee acceptance has 
been raised as an important issue, because they can fear 
replacement through AI [13, 17]. Therefore, an open, 
experimental, and data-driven culture is expected to 
drive AI adoption [23]. 
From an environmental perspective, different 
external factors impact organizational AI adoption. 
First, this includes government regulations and industry 
specifics [24]. For example, regulations like the General 
Data Protection Regulation (GDPR) complicate AI 
adoption in most industries. Moreover, certain regulated 
industries like public health care or car manufacturing 
tend to face additional challenges [10, 13]. Second, a 
competitive market might drive AI adoption [17]. For 
example, financial services industries are facing fintech 
startups as competitors that, in some instances, very 
successfully rely on AI systems [14]. Novel startups and 
business models can also be observed in health care [cf. 
25]. Third, customer AI readiness has been mentioned 
as an important factor [17, 22]; a customer group might 
not want to communicate with an AI system for various 
reasons [17], such as when the system produces wrong 
or discriminating outputs.  
Current research faces two limitations when 
regarding AI adoption in health insurance. First, only 
few studies have considered AI adoption in healthcare 
insurance, despite the great potential and particular 
challenges for AI adoption in this domain [10]. Second, 
many factors have been identified across industries that 
influence the adoption of AI technology, but our 
understanding of how organizations go about selecting 
and prioritizing different use cases to drive AI adoption 
remains limited. Hence, we explore AI use cases and 
prioritization criteria for health insurance. 
3. Research Approach 
We selected an interpretive research stance [26] to 
explore AI use cases and possible prioritization criteria 
for health insurance, as AI adoption is still at an early 
stage. We conducted exploratory interviews with health 
insurance experts, including managers, developers, data 
scientists, and consultants, allowing the representation 
of many different voices and viewpoints [27] on AI 
adoption. Nevertheless, we had to keep in mind that the 
interviewees only reported on their personal viewpoints 
and experiences [28]. In the following, we depict our 
approach to data collection and data analysis. 
3.1 Data Collection 
For data collection, we conducted exploratory 
interviews with health insurance experts. We prioritized 
experts in different roles and positions with AI 
experience, including managers, developers, data 
scientists, and consultants. By including both experts 
from industry and consulting (pseudonymized as IN and 
CO, respectively), we were able to cover internal and 
external perspectives. This sampling allowed us to 
capture many different viewpoints, which in turn helps 
addressing potential biases in the data [29]. Although we 
managed to interview both technical and business 
experts within the external group of interviewees, we 
could not interview an individual holding a business role 
within the internal group. We were declined multiple 
times, as the COVID-19 pandemic kept health insurers 
busy during our study. Table 1 provides an overview of 
the interviews. 
 
Table 1. Interview partners 
ID Position Duration 
(min) 
Date 
IN1 Data Scientist 51 11/2020 
IN2 Senior Data Scientist 31 12/2020 
IN3 Software Developer 34 12/2020 
CO1 Senior Consultant 39 10/2020 
CO2 Director 23 10/2020 
CO3 Manager 37 10/2020 
CO4 Senior Consultant 28 11/2020 
 
We conducted a total of seven interviews between 
October and December 2020. We used semi-structured 
interview guidelines, which allowed for a certain level 
of flexibility to explore interesting directions [27]. We 
asked our experts on existing and planned AI initiatives 
within companies, other potential use cases, and criteria 
that guide use case prioritization along the AI adoption 
journey. The interviews lasted 35 min on average. Some 
interviewees provided brief responses, while others 
provided rich information even beyond the scope of this 
study. We recorded and transcribed each interview for 
data analysis and interpretation.  
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3.2 Data Analysis 
For data analysis, we followed an iterative approach 
that included data coding with increasing levels of 
abstraction as well as the constant comparison of the 
data with our emergent findings [29]. After five to six 
interviews, we did not gain substantially new insights 
for the purpose of our explorative study. Hence, data 
collection stopped after seven interviews and data 
analysis began. The analysis was guided by our 
understanding of the topic, which we built from prior 
literature (cf. Section 2.2) and our own fieldwork. While 
one researcher took the lead in data coding, we regularly 
discussed the emergent findings within the research 
team and checked for potential biases. 
We coded our data following the procedure by 
Gioia, et al. [30], as we sought to find similarities and 
differences in the data. As a first step, we coded our data 
with first-order codes, which were closely aligned to the 
domain and language of the interviewed experts. We 
then organized and grouped them into second-order 
themes, which are closer to the researchers' domain. 
Thereafter, we derived theoretical aggregate dimensions 
from the second-order themes. This last step allowed us 
to organize and interpret our findings. Figure 2 
illustrates the coding scheme. 
4. Results  
We identified a plethora of AI use cases in the areas 
of predictive health, individualized service, anomaly 
detection, and operations enhancement. Our data led us 
to suggest that health insurers prioritize these use cases 
according to implementation complexity and business 
orientation. In the following, we will depict these 
findings in more detail. 
4.1 AI Use Cases for Health Insurance 
We identified a plethora of use cases for AI, and as 
a result of our coding procedure, we grouped these use 
cases into four categories: predictive health, 
individualized service, anomaly detection, and 
operations enhancement (Table 2). 
First, health insurers can apply AI for predictive 
health and service management. Here data from 
doctors, hospitals, insured persons, and drug producers 
can be integrated for promising use cases for predictive 
and preventive health care. Examples include the early 
detection of various diseases, the management of 
disease progressions, or the prediction of potential drug 
interactions. For instance, personal movement data 
might be leveraged to predict bouts of depression, 
potentially preventing diseases or enhancing current 
treatment and curing procedures. This also holds great 
potential for health insurers to save costs: “an insured 
person who is healthy also incurs fewer costs with a 
health insurance company” (IN2). This makes 
predictive health and service management especially 
attractive for stationary care, which is a key cost driver 
for health insurers: “If you look at the annual reports 
and also the costs of the health insurance funds, then 
you see that hospitals are the biggest cost drivers. There 
is an extremely large savings potential there” (CO1). 
Second, health insurers can apply AI for 
individualized service and communication. Using the 
AI models and individual data of the insured, health 
insurers can offer individualized care services and 
analyze customer interaction data to try predicting and 
preventing customer churn. Although individualized 
services and communication are not new, our data 
suggest that AI allows us to carry out this task more 




Approach less complex 
use cases first
Data accessibility drives 
complexity
• Complex AI use cases are not the best way to 
approach AI
• Process findings from small AI projects first
• Gather experience before approaching difficult use 
cases
• Easier to start with rich available data, e.g. data on 
invoices or diagnoses
• Legal obstacles when reaching out for data, e.g. for 
hospitals, pharmacies, physicians
• …
• Focus on use cases with little consequences, e.g. 
administrative tasks
• Potential for discrimination with patient-orientated use 
cases
• …










Use case implications drive 
complexity
Figure 2. Exemplary Coding scheme 
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describes: “You can imagine that such initiatives 
already exist on a large scale among statutory health 
insurers. In other words, they approach the insured and 
make them offers on how their health can be improved. 
Until now, however, this has been relatively 
unstructured and untargeted. And because we now have 
data going back many years, we can simply unleash a 
machine learning algorithm on it and see whether this 
algorithm uncovers patterns that a human worker may 
not have been aware of before” (IN2). 
Third, health insurers can apply AI for anomaly 
detection. Fraud detection for insurance claims 
represents a promising use case here, especially to save 
costs. Our data suggest that some health insurers have 
already implemented this. From their perspective, “it 
was clear very early on that this is a big issue. That's 
why it was one of the first projects that was tackled, and 
accordingly it is already in a productive environment” 
(IN2). Additionally, following a new German regulation 
from 2020, “a health insurance company has now only 
the possibility to give a certain percentage of invoices 
[to an external auditor …]” (CO1), which makes this 
use case even more attractive. Another high potential 
area is the detection of incorrect medications, as this 
typically means “that a patient is now receiving too 
much or the wrong medication and therefore needs 
something else. This makes the whole case more 
expensive overall” (CO3). 
Fourth, health insurers can apply AI for operations 
enhancement. The main purpose is to automate and 
streamline supporting processes within the company, 
including insurance claims processing, payment order 
verification, or customer support. For instance, health 
insurers might apply AI to automatically process follow-
up prescriptions, “so that there's not a person having to 
sift through a prescription again and again, which just 
leads to a lot of fairly trivial decisions being taken away 
and [we] speed up that whole process a little bit” (IN2). 
Another example, chatbots might be integrated into 
customer support to automate customer service and 
consultation (IN3). Implementing such might “lower the 
administrative overhead, leading to faster response 
times. This also leads to greater satisfaction on the part 
of the insured and more money for other things” (IN1). 
Nevertheless, the interviewees propose that the business 
value potential for operations enhancement is lower as 
compared with that of predictive health and anomaly 
detection. 
Table 2. AI Use Cases for Health Insurance 
Predictive Health and Service Management 
• Prediction and early detection of diseases, e.g., 
strokes, heart attacks, or diabetes 
• Prediction and management of disease 
progressions 
• Prediction of preventive measures against diseases 
• Prediction of potential drug interactions 
• Prediction of customer costs for service 
management 
Individualized Service and Communication 
• Generation of individualized services and tariffs 
• Analyses of customer interaction data for customer 
communication management 
• Prediction of customer churn 
• Independent consultation through an AI bot 
Anomaly Detection 
• Fraud detection for insurance claims 
• Detection of incorrect medications 
Operations Enhancement 
• Automation of internal document processing 
• Automated verification of insurance applications 
or payment orders 
• Management and steering of internal processes 
• Automation of customer support through chatbots 
4.2 Prioritization Criteria for AI Use Cases 
Beyond identifying AI use cases, we further asked 
our experts how they prioritize these use cases as part of 
their AI adoption. We discovered two categories of 
criteria that likely influence prioritization: 
implementation complexity and business orientation. 
Following these criteria, health insurers are likely to 
prioritize different use cases for actual implementation. 
Table 3 provides an overview of the identified criteria. 
In the following, we depict our findings in more detail. 
Table 3. Prioritization criteria for AI use cases 
Aggregate dimension Use case criteria 
Implementation 
complexity 
• Use case implications 
• Data accessibility 
• Data sensitivity 
Business orientation • Use case value 
• Strategic alignment 
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4.2.1 Implementation Complexity. Our data suggest 
that health insurers prioritize according to 
implementation complexity, which we view as a 
technological factor. There are manifold AI use cases 
for health insurance, and as AI was a novel topic for the 
health insurers in our sample, the common theme is to 
start with simple use cases (CO2). This would allow 
health insurers “to process findings from the first 
projects correctly and also to draw the right conclusions 
from them in order to be able to scale […] and to be 
able to realize the added values of AI across the entire 
organization” (CO1). For our interviewed experts, this 
observation would mean to focus on operations 
enhancement and anomaly detection first (CO2). The 
“more complex [use] cases in the area of prediction of 
disease progression and […] also individualized 
customer service, [are] perhaps not the best solution in 
my opinion to approach the topic of AI” (CO1). More 
complex use cases should then only be approached by 
more experienced organizations. Figure 3 illustrates the 
possible prioritization of AI use cases according to 
implementation complexity for German statutory health 
insurers. Figure 3 classifies use cases based on our 
qualitative data. It indicates the interviewees' individual 
assessments and thoughts, rather than ground truth facts 
or a quantitative ranking. 
Our data suggest that the implementation 
complexity of AI use cases can be described by three 
criteria. First, use case implications influence 
implementation complexity. Here, use cases that are 
solely working internally (and not facing the customer) 
tend to be simpler to realize. As a health insurance 
employee states, “the things with little consequences are 
processed first –that is, for the insured. So, you first 
automate the administration, which of course already 
leads to benefits” (IN1). In other use cases, such as 
predictive health or individualized services, the AI 
models' decisions can have serious consequences 
(CO3). A health insurance data scientist explains: “since 
it is a statistical procedure, […] you have to make sure 
that no patients are excluded from a program that might 
be useful for them and that they are not put in a worse 
position […] This must not be the case” (IN1). Here, the 
decision of the AI system typically needs to be 
reasonable and explainable to customers. This helps to 
address potential issues of discrimination (IN2). 
Second, data accessibility needs to be considered 
for implementation complexity. Health insurers 
typically have a large pool of high-quality data that can 
and should be used early on (e.g., data on diagnoses or 
invoices (CO4)). As a consulting director reported, 
“statutory health insurers have data in use cases [such 
as] service management, drugs, drug fraud, and so on, 
and there are opportunities to quickly develop best 
practices with existing data and very inward-looking 
use cases” (CO2). If the data required for a use case are 
not easily accessible, this would imply cooperating with 
other parties, like other health insurers or hospitals. This 
typically leads to additional complexity and potential 


























Early focus on simple use cases that 
help to gather experience with AI
Later focus on complex use cases that 
involve more strategic considerations
Figure 3. AI Use Case Prioritization by Implementation Complexity 
Note: The AI use cases have been classified qualitatively. The figure indicates the interviewees' individual 
assessments and thoughts, rather than ground truth facts. 
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employee explains, it is even “outside of [their] current 
legal ability to actively reach out to hospitals, 
physicians, pharmacies, and so forth and ask them to 
share data with us so that we can improve our analytics” 
(IN3). 
Third, the data sensitivity required for the use case 
also plays an important role as there is often sensitive 
and personal data involved that need to be protected at 
all costs, which adds to implementation complexity. 
Having a data leak “would really be the worst-case 
scenario, because you can't have any more sensitive 
data than that what we have as data” (IN3). To address 
this, dedicated security mechanisms need to be 
implemented (IN2). Health insurers need to adhere to 
strong German regulations (e.g., the GDPR or the social 
code (CO3)). This also implies that health insurers 
cannot use all data for all purposes. Instead, they need 
to “have as legal a mandate to do that” (IN3). Here, 
working with less sensitive and regulated data is simpler 
to start with at the beginning of the AI adoption.  
 
4.2.2 Business Orientation. Besides implementation 
complexity, our data suggest that health insurers should 
also prioritize use cases according to their business 
orientation, which we view a predominately 
organizational factor. Other than in the case of 
implementation complexity (focus on simple use cases 
first), our interviewed experts did not have a clear 
recommendation here. Instead, a health insurer needs to 
assess its own business orientation and prioritize AI use 
cases accordingly to fit its needs. 
One criterion to consider is the expected use case 
value for business. The previously identified categories 
of use cases focus on different value targets. As an 
example, predictive health addresses the general 
prevention of diseases, which is expected to reduce 
harm and insurance costs (CO3). As a senior data 
scientist explains, if “statutory health insurers raise the 
health of their insureds so much […] you will of course 
also be able to press the costs there” (IN2). As another 
example, operations enhancement is expected to 
optimize back-office processes, which drives internal 
efficiency. “Where an application used to take three 
weeks to process, it now could be done in a matter of 
hours, if not minutes” (IN3). This saves resources for 
health insurers and might also lead to more satisfied 
customers (IN2). Although all value targets are highly 
relevant for health insurers, the current situation around 
the COVID-19 pandemic led some experts to argue that 
cost savings should be prioritized early on. As a senior 
consultant puts it, “especially with the pandemic 
situation and also with the financial holes that are in the 
budget of the health insurance companies, of course the 
focus one and the focus two and the focus three is on 
cost savings” (CO1). This mostly complements the 
focus on internal and less complex use cases (cf. Figure 
3), as “cost savings is something which can be quickly 
achieved” (CO2). 
Besides use case value, the strategic alignment of 
health insurers with use case implementation is an 
important criterion. A consulting manager explains, “it's 
a strategic decision. It depends a little bit on whether 
you think you have to become digital organization 
really, really fast and you also invest what it takes or 
whether you say, ‘I want […] to try it first and see how 
it is and see how it develops’” (CO3). Some use cases 
require larger investments or other strategic decisions 
for successful implementation. For example, to gather 
enough data to train an AI model, collaborations and 
sharing of data with external partners might be required. 
“When several health insurance companies join forces, 
the data pool is of course better and the quality of an AI 
model is better” (IN2). However, from competitors' 
perspective, that is potentially undesirable, especially if 
the health insurer already has a large data pool (IN2). In 
that case, it is a strategic decision for a health insurer to 
prioritize a use case that starts collaborations with 
external partners. As another example, certain use cases 
go beyond incremental improvements and have strategic 
implications for the business model. Like with 
predictive health, these use cases would typically 
augment the existing service portfolio. It would enable 
a health insurer to “position itself as a health advisor 
with the data it has on the insured and go more into 
prevention instead of […] the previous role, which is 
more in benefits and service management” (CO2). Here, 
it is a question of whether the health insurer wants to 
develop into a health advisor or stay with the core 
business. Therefore, use case prioritization should also 
follow strategic alignment considerations. 
5. Discussion 
Health insurers stand to benefit from AI adoption, 
as they typically have access to vast amounts of data. 
However, AI adoption is a challenging endeavor in 
practice. Extant research has thus far not investigated AI 
adoption specifically for health insurance. Therefore, 
we conducted explorative interviews with health 
insurance experts. We identified a plethora of AI use 
cases in the areas of predictive health, individualized 
service, anomaly detection, and operations enhance. In 
addition, we and found that health insurers are likely to 
prioritize these use cases according to implementation 
complexity and business orientation. In the following, 
we will discuss our findings against the background of 
extant research as well as our contributions to theory and 
practice, limitations and avenues for future research.  
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5.1 Implications for AI Adoption 
Previous research has identified various 
technological, organizational, and environmental 
factors that influence the decision of adopting AI, 
whereas AI has been mostly viewed as a monolithic 
concept. We explored how health insurers would use 
these factors to prioritize different use cases for AI 
adoption, finding that implementation complexity and 
business orientation are most likely the important 
factors. Our findings further suggest that health insurers, 
who in our sample had only little experience with AI, 
would focus on simpler use cases first to gather 
experience, whereas more complex use cases should be 
mastered later in the AI adoption.   
Implementation complexity can mostly be 
described by use case implications, data accessibility, 
and data sensitivity. The importance of data in adequate 
quantity and quality has been repeatedly mentioned in 
literature as an organizational factor for AI adoption [10, 
12, 13]. This is not surprising, as today's AI systems 
mostly learn from data. Besides, research has also 
acknowledged the role of environmental factors, such as 
the regulatory context and customer AI readiness [13, 
17, 22]. These environmental factors encourage health 
insurers to prioritize use cases, as manifested by the 
factors use case implications and data sensitivity. 
However, we would have also expected to find that 
different types of AI technologies are an important 
factor for implementation complexity as well. For 
example, having a deep learning algorithm that cannot 
be precisely explained might raise implementation 
complexity [31]. Potentially, our interviewed experts 
were unaware of this potential factor because of AI 
adoption's early stages in health insurance. 
As our study investigated prioritization criteria for 
different use cases (instead of adoption factors for AI as 
a monolithic technology), we conclude that not all 
factors are equally relevant for each AI use case. For 
example, data access or regulatory aspects must not be 
a challenge for AI use cases that focus on internal 
operations. As another example, the business value of 
predictive health might be more focused on patient 
health and cost reduction, whereas individualized 
services target customer satisfaction. Therefore, we 
conclude that research and practice should consider AI 
adoption in a more nuanced way to respect the nature 
and implications of different use cases and AI 
technologies. 
Building on the initial research on AI adoption 
[e.g., 32], we contribute to the understanding of 
strategic considerations for AI adoption. First, we can 
see that certain AI use cases imply changes to the core 
business model of health insurers. For example, 
focusing on predictive health would position an insurer 
as a health advisor, whereas other use cases such as 
operations enhancement or anomaly detection target 
improvements of existing business processes. Hence, 
the prioritization of use cases goes alongside strategic 
considerations, highlighting the strategic value of AI. 
Second, we found that developing more complex use 
cases requires organizational commitment and 
investments in appropriate resources. For example, 
organizations first need to acquire new know-how or 
gather experiences with simpler use cases. Therefore, 
we conclude that AI adoption requires organizations to 
continuously adapt themselves (and their AI readiness) 
during the adoption process, as also proposed by Jöhnk, 
et al. [22]. This enables organizations to build AI 
capabilities and successfully approach more complex AI 
use cases. Third, AI adoption might stimulate 
organizations to involve new partners to form rich 
platform ecosystems [33] that fuel AI implementation. 
Such ecosystems could potentially consist of health 
insurers, doctors, hospitals, drug producers, and 
software companies [34]. Hence, there are new 
opportunities for collaboration and participation, which 
should be closely examined in the context of health 
insurance and AI adoption. The strategic relevance of 
AI also confirms the importance of industry and market 
characteristics as an environmental factor for AI 
adoption, as suggested by previous findings [12, 17]. 
5.2 Contributions to Theory and Practice 
This study contributes to the ongoing discourse on 
the use of AI surrounding health care. We expand our 
understanding of AI adoption in health insurance with 
its unique regulatory context and data sensitivity. 
Specifically, we focus on the little explored area of AI 
use case prioritization. Thereby, we advance extant 
research on AI adoption that predominately investigated 
factor for the adoption decision early in the process. In 
addition, we provide a new perspective by 
differentiating between use cases (with different 
characteristics) rather than viewing AI as a monolithic 
concept. This revealed that previously known factors on 
AI adoption do not apply equally well for different use 
cases. We conclude that researchers and practitioners 
should take a more nuanced view of AI adoption to 
respect different use cases and AI technologies. 
We also provide valuable insights for practice. 
Health insurance practitioners could use our findings as 
a starting point for their AI adoption decision making. 
We provide a structured list of AI use cases and criteria 
that can be used to prioritize use cases, enabling insurers 
with little AI experience to identify and prioritize 
suitable use cases and develop a roadmap for AI 
adoption. 
Page 3969
5.3 Limitations and Future Research 
This study has certain limitations. To explore AI 
use cases in health insurance and identify respective 
prioritization criteria, we relied on a qualitative research 
approach. Although this approach is well aligned with 
our research questions, it is prone to inherent 
weaknesses. Among them is researcher bias when 
interpreting our interview data [26, 29]. Although it is 
impossible to completely erase researchers' personal 
views and preconceptions, we mitigated bias by 
considering multiple perspectives as part of our 
sampling strategy. Additionally, we focused on German 
statutory health insurance system in this study. 
Although we argue that our findings are well applicable 
to health insurers in other countries as well, our sample 
of health insurance representatives was limited to 
organizations that are beginning their AI adoption 
journey. Hence, more experienced organizations might 
consider different factors for use case prioritization, 
such as the complexity of different technologies. 
Finally, we conducted a total of seven interviews, as this 
study aimed at exploring AI use cases for health 
insurance and the respective prioritization criteria. 
Although we argue our data are sufficient and yielded 
interesting insights, we acknowledge that more data 
would further increase the confidence in our findings 
and potentially allow us to distill more generalizable 
theoretical contributions. 
Our study opens up new avenues for future 
research. By conducting a longitudinal case study within 
a health insurance company, we gained additional 
insights into how use case prioritization might 
progressively shift as organizations gain further 
experience or change their strategy. In addition, future 
research might look into AI use case prioritization in 
other contexts regarding the healthcare domain. This 
would help to further refine and assess our findings, 
especially with regards to generalizability. 
6. Conclusion  
 Health insurers can benefit from AI as they 
typically have access to vast amounts of data. However, 
practitioners struggle with AI adoption, and previous 
research lacks an overview of AI use cases in health 
insurance and prioritization criteria that can guide 
adoption. To address this, we conducted exploratory 
interviews in the German statutory health insurance 
system. We identified AI use cases in predictive health, 
individualized service, anomaly detection, and 
operation enhancement. We also found that health 
insurers are likely to prioritize these use cases by 
implementation complexity and business orientation. 
Experts recommend focusing on simple use cases first 
to gain experience with AI, before approaching more 
complex use cases that involve more strategic 
considerations. 
We contribute to an ongoing discourse on AI 
adoption in healthcare research. Moreover, we provide 
a novel perspective on AI adoption by differentiating 
between use cases, instead of viewing AI as a 
monolithic concept. We conclude that research and 
practice should consider AI adoption in a more nuanced 
way. Our findings serve as a valuable tool for health 
insurance practitioners to support AI adoption decision 
making. We provide a structured list of AI use cases and 
criteria for use case prioritization. 
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